SCHEMBL4498647

SCHEMBL4498647

COC(=O)c1cc(C(=O)c2c(C)c(NC(=O)c3cccc(OC(C)=O)c3)c3ccccn23)ccc1N

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
HTT P42858 3/20 0.41
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
HPGD P15428 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPT P10636 3/20 0.38
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
PKM P14618 1/20 0.37
RECQL P46063 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1572983 0.93 MEN1 (0.41) ALDH1A1HTTNPC1TP53RAB9A
SCHEMBL13918698 0.90 ALDH1A1 (0.39) ALDH1A1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4507657 0.89 HDAC3 (0.42) ALDH1A1HTTSMN1; SMN2MEN1KMT2A
SCHEMBL13918694 0.88 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2MEN1KMT2AHPGD
SCHEMBL4507260 0.88 MAPT (0.38) ALDH1A1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL150004 0.86 MAPT (0.46) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL4512025 0.85 ALDH1A1 (0.37) ALDH1A1HTTSMN1; SMN2MEN1KMT2A
SCHEMBL1573171 0.81 NR1H4 (0.42) ALDH1A1MEN1KMT2AHPGDNPSR1
SCHEMBL3590127 0.81 KMT2A (0.45) ALDH1A1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4518702 0.81 MEN1 (0.38) ALDH1A1HTTTP53SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9120819-B2 FGF-receptor agonist dimeric compounds SANOFI (FR) 2015-09-01 US disclosed
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI-AVENTIS (FR) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS FGF2, FGFR1, FGF1 ALDH1A1 1044/4885HTT 4673/4885NPC1 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.